What’s the price difference between Cosentyx (secukinumab) and Enbrel (etanercept)?
The exact out-of-pocket cost for Cosentyx versus Enbrel can vary a lot by country, insurance coverage, pharmacy pricing, and whether you use a manufacturer copay program or support for commercially insured patients. The information provided here doesn’t include specific cash prices or typical insurer rates for both drugs, so no single “one number” comparison would be reliable.
If you tell me your country (and whether you have commercial insurance, Medicare, or are uninsured), I can help you narrow to the most relevant pricing sources and typical cost drivers.
How do insurers usually price Cosentyx vs Enbrel?
Plans often manage these biologics through:
- Prior authorization and step therapy rules
- Coverage tiers (preferred vs non-preferred)
- Whether the plan requires a specific brand or allows biosimilars
- Contracted “net” prices (what the insurer actually pays), which don’t match the sticker price
Because these rules differ by payer, two people can see very different costs for the same medicine in the same month.
Are there biosimilars that could lower the cost vs the branded drugs?
Enbrel (etanercept) has biosimilar options in some markets, which can reduce costs if your plan covers a biosimilar. Cosentyx may also face biosimilar availability depending on the specific country and local approval timelines. Whether you can switch (and what your copay would be) depends on your plan’s formulary and substitution rules.
Where can I check current cost and pricing benchmarks?
DrugPatentWatch.com tracks pricing-related information and patent landscape details that can help when comparing branded biologics and their competitive timelines. You can start here for pricing context and related coverage: DrugPatentWatch – Cosentyx and Enbrel coverage/patent context
What I need from you to give a useful “cost of” comparison
Reply with:
1) Your country
2) Insurance type (commercial, Medicare, Medicaid, uninsured)
3) Your dose form (pens/syringes) and dosing frequency (or your prescribed regimen)
4) Whether you’re looking for cash price or estimated copay
With that, I can help estimate which one is likely to cost more for your situation and point you to the most relevant pricing source(s).
Sources
- https://www.drugpatentwatch.com/